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Nanotechnology in Biomaterials
Electrospun polyurethane as an
alternative ventricular catheter and
in vitro model of shunt obstruction
Supraja Suresh and Richard A Black
Abstract
Intracranial pressure and volumevary considerably between hydrocephalic patients, andwith age, health and haemodynamic
status; if left untreated, intracranial pressure rises and the ventricular system expands to accommodate the excess cere-
brospinal fluid,with significantmorbidity andmortality. Cerebrospinal fluid shunts in use today have a high incidence of failure
with shunt obstruction being the most serious. Conventional proximal shunt catheters are made from poly(dimethyl)silox-
ane, the walls of which are perforated with holes for the cerebrospinal fluid to pass through. The limited range of catheters,
in terms of material selection and flow distribution, is responsible in large part for their poor performance.
In this study, we present an alternative design of proximal catheter made of electrospun polyether urethane, and evaluate
its performance in the presence of glial cells, which are responsible for shunt blockage. The viability and growth of cells
on catheter materials such as poly(dimethyl)siloxane and polyurethane in the form of cast films, microfibrous mats and
porous sponges were studied in the presence of proteins present in cerebrospinal fluid after 48 h and 96 h in culture. The
numbers of viable cells on each substrate were comparable to untreated poly(dimethyl)siloxane, both in the presence
and absence of serum proteins found in cerebrospinal fluid. A cell culture model of shunt obstruction was developed in
which cells on electrospun polyether urethane catheters were subjected to flow during culture in vitro, and the degree of
obstruction quantified in terms of hydraulic permeability after static and perfusion culture. The results indicate that a
catheter made of electrospun polyether urethane would be able to maintain cerebrospinal fluid flow even with the
presence of cells for the time period chosen for this study. These findings have implications for the design and deploy-
ment of microporous shunt catheter systems for the treatment of hydrocephalus.
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Introduction
Hydrocephalus is a neurological condition charac-
terised by the accumulation of cerebrospinal ﬂuid
(CSF) in the ventricles or cavities of the brain,
brought about by an imbalance in formation and
absorption of CSF. Hydrocephalus is an incurable
condition at present.1 The most common treatment
option available is implantation of a CSF shunt
device, to divert the excess CSF to another part of
the body, where it is absorbed. Although the mortality
rate has decreased since their introduction in the
1950s, the incidence of shunt failure remains unaccept-
ably high, which may be attributed in part to the lack
of substantial investment in the advancement of the
technology.2,3
Ventricular shunts fail for many reasons, but the fail-
ure that causes the greatest impact is obstruction of the
catheter, proximal occlusion being the most common.4
Clinical reports indicate that 20–30%of shunt failures in
the ﬁrst year of surgery are caused by obstruction.5 The
main sources of obstruction are the glial cells, which
invade the perforations (fenestrations) in the walls of
the ventricular catheter, preventing the entry of the
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CSF.6 The obstruction in all cases necessitates replace-
ment of the catheter, which, in turn, may lead to further
complications and discomfort for the patient.7
Since shunt devices were introduced, several
improvements in shunt design have been made, includ-
ing alternative drainage locations, ventricular catheter
placements, new valve and catheter assembly designs,
and anti-siphon and on–oﬀ devices that bring about
gravity-actuated changes in opening pressure and exter-
nally adjustable valves.8 Nevertheless, to date, there is
no one valve that is proven to be superior.2 Arguably
one of the most promising avenues of research being
explored at present involves creating a smart shunt in
which the valve is capable of being controlled remotely.
A shunt that can regulate CSF more eﬀectively, and is
less susceptible to malfunction, would have obvious
beneﬁts to the patient.5,9 Although such advances
would represent a milestone in hydrocephalus shunt
device development, a blocked catheter will inevitably
lead to revision surgery.10
There is a lack of design criteria for the proximal
catheter available at present.6,11,12 More than 80% of
the perforations present in the proximal catheter are
not in use at any given time, and they may become
easily blocked.11 Conventional catheters are made of
poly(dimethyl)siloxane (PDMS), with few exceptions,
and although there are studies which involve surface
modiﬁcation of PDMS to reduce the cell attach-
ment,7,13,14 few, if any, studies have considered micro-
porous materials for this application.
The aim of this study was to evaluate the hydraulic
performance and cell growth characteristics of a micro-
ﬁbrous proximal catheter in comparison to conven-
tional catheter materials.
Materials and methods
Catheter material preparation
The candidate catheter materials chosen for this study
were medical-grade PDMS (Silastic MDX4210, Dow
Corning Corp., Midland, MI, USA; ImmobaSil,
Ashby Scientiﬁc Ltd, Coalville, UK) and polyurethane
(b9
TM Series ‘A’, Biomer Technology Ltd, Runcorn,
UK; Tecoﬂex SG-80A, Thermedics Polymer
Products, Woburn, CA, USA) in the form of cast ﬁlms,
microﬁbrousmats andporous sponges.A silicone hydro-
gel (Nelﬁlcon ‘A’, CIBA VISION Corp., Duluth, GA,
USA) served as negative control.
The materials to be evaluated in contact with cells
were prepared and secured by means of a short length
of ﬂuorinated polyethylene tubing in the bottom of
96-well polystyrene plates, with blank wells serving as
positive control. Silastic MDX4210 biomedical grade
elastomer was prepared according to the manufacturer’s
instructions. Approximately 20 ml of the combined solu-
tionwas injected into the base of eachwell and allowed to
cure at 50Cfor 12 hbefore seedingwith cells. ImmobaSil
porous microcarriers were cut so as to ﬁt the base of the
each well. Polyurethanes Z1A1 and Z3A1 pellets were
dissolved to a concentration of 15% w/w in dimethyfor-
mamide by mixing on a roller mixer for 48 h at room
temperature and atmospheric pressure. Thereafter,
each polyurethane solution was cast into glass petri
dishes and the solvent removed at 65C under a
vacuum of 45 kPa for 48 h. The resulting cast ﬁlms were
detached from the petri dishes and soaked in deionised
water for 24 h before use to ensure complete removal of
all remaining solvent. The surface exposed to air was
used so as to eliminate any variation attributed to the
polymer in contact with the petri dish surface.15
Microﬁbrous polyurethane (electrospun polyether
urethane, EPU) catheters were produced according to
an electrospinning protocol described by Andrews
et al.16 The morphology of the EPU material was deter-
mined by the scanning electronmicroscopy (Hitachi TM
1000 SEM Hitachi High-Technologies Europe GmbH,
Krefeld,Germany), inwhich a small portionof the cathe-
ter was cut and aﬃxed to a stub ready for imaging.
Micrographs of both the inner and outer surfaces of
the electrospun material were acquired and analysed to
determine the pore size, diameter and alignment of the
ﬁbres.
Cell culture protocols
Primary astrocytes were isolated from 1- or 2-day-old
neonatal rat pups that had been sacriﬁced according to
UKHomeOﬃce guidelines. The cortices were separated
from the brain, minced and suspended in phosphate-
buﬀered saline (PBS). The minced samples were then
sieved through 100 –mm cell strainer using a sterile glass
tissue grinder, followed by passage through a 70 –mm cell
strainer, and the samples were collected in a centrifuge
tube. After a 5-min centrifugation at 800 rpm, the sample
was resuspended in 5ml Dulbecco’s modiﬁed Eagle
Medium supplemented with 10% fetal bovine serum,
1% penicillin/streptomycin and 1% nonessential amino
acids. The cell suspension was seeded at 3 105 cells/cm2
in a tissue culture ﬂask and incubated under a 5% CO2
atmosphere at 37C. After reaching 80% conﬂuence, the
ﬂaskwas shaken at 60 rpm for 12 h to remove other types
of cells. Immortalised mouse ﬁbroblast (3T3) cells were
established fromNIH Swiss mouse embryo and cultured
in identical growth medium.
Protein adsorption and cell seeding
The plates were sterilised under a UV lamp for 15min
before culture. Bovine plasma ﬁbronectin (Fn) (2 g/ml)
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(Invitrogen, Paisley, UK) was diluted in PBS to a ﬁnal
concentration of 4 mg/ml. Twenty micro litres of this
solution was added to cover the surface of the material
in each well and left in incubator for 1 h at 37C. Any
unbound Fn was removed by washing twice with PBS.
The treated surface was then blocked by adding 20 ml of
1% w/v bovine serum albumin (BSA) (Sigma-Aldrich,
Gillingham, UK) for 1 h at 37C. After the time period
for incubation the excess BSA was removed by washing
twice with PBS. The surface was not allowed to dry out
at any stage during the surface treatment process. NIH/
3T3 cells or primary astrocytes were cultured under
static conditions at a seeding density of 1.2 104
cells/cm2 on samples of each material, which were
secured to the base of a 96-well plate as before.
Fluorescence microscopy
Samples of the cast ﬁlms and silicone foam (SF)
were prepared as above and incubated with astrocytes
for 96 h prior to imaging. The samples were washed
with PBS twice, incubated with LIVE/DEAD
(Molecular Probes, Invitrogen) viability assay for
30min, and again washed with PBS twice before view-
ing under a ﬂuorescence microscope (Zeiss Apotome,
Carl Zeiss Ltd, Welwyn Garden City, UK).
Cell viability assessment
Cell viability was determined quantitatively using an
established viability assay (alamarBlue ABDserotec,
Kidlington, UK). The alamarBlue (AB) assay exploits
the natural ability of cells to induce an oxidation–
reduction (REDOX) reaction that give rise to changes
in ﬂuorescence and colour of an indicator dye. Hence,
an increase in cell numbers gives rise to progressively
greater reduction, whereas inhibition of cell growth (or
cell death) maintains the dye in its oxidised form and
colour. AB was added to fresh medium to a ﬁnal con-
centration of 10% by volume, and incubated with each
sample for 24 h (6 h in the case of the perfusion study
owing to the higher cell seeding density). Thereafter,
the medium was transferred to the wells of a 96-well
plate and read in a plate reader (Multiskan Ascent).
The end time points in the case of the static tests
were 48 h and 96 h, and immediately after seeding
(t¼ 6 h) and after 12 h of perfusion in the shunt
obstruction model. The measured absorbance values
were converted according to the calculations detailed
in the manufacturer’s instructions, and expressed as a
percentage to indicate the amount by which the AB dye
is reduced by the cells. The percentage reduction in AB
was taken as a measure of the number of viable cells
present on each surface and at each time point. The
viability data presented for the perfusion studies are
expressed relative to the mean values for the after
seeded catheter.
Quantification of EPU catheter obstruction
The hydraulic permeability of the electrospun form of
polyurethane catheter material (EPU) in the presence of
NIH/3T3 ﬁbroblasts was taken as a measure of shunt
obstruction in the in vitro model. The cells were seeded
on the luminal surface of the microporous catheter at a
seeding density of 3.5 104 cells/cm2. The catheter sec-
tions were 4 cm in length and 3mm in diameter. The
catheter was then rotated on roller table at 37C at 5%
CO2 for 6 h to achieve a uniform distribution of
cells. After seeding, one catheter section was main-
tained in a static environment and used as a control
group for this study.
Perfusion of the growth medium represented the
ﬂow of CSF for the purposes of this study. The
medium was delivered by means of a syringe pump at
a constant ﬂow rate of 0.07ml/min for the duration of
each test (12 h). The chosen ﬂow rate corresponds to
ﬂow of CSF through an actual ventricular catheter. The
distal end of the catheter was blocked so that the
medium permeated through the walls of the catheter.
The resulting perfusate accumulated in the T-25 ﬂask in
which each catheter was secured (Figure 1). The sam-
ples subject to perfusion and those cultured under static
conditions were incubated with medium containing AB
for 6 h prior to measurement in the plate reader. Cell
viability was assayed at two points: immediately after
seeding (t¼ 6 h) and after 12 h of perfusion (t¼ 24 h).
Thereafter, the perfusate was transferred to a 96-well
plate and the syringe replenished with fresh medium for
the remainder of the experiment (or until the next meas-
urement point). The resulting viability data were
expressed relative to the values recorded for the EPU
catheters immediately after seeding (Figure 5).
The hydraulic permeability of each length of EPU
catheter was measured at the beginning and conclusion
of each test with the aid of a computer-controlled shunt
testing apparatus based on a dynamic mechanical ana-
lysis system (Bose Electroforce 3200, Bose Corp.,
Eden Prairie, MN, USA). The apparatus recorded the
pressure drop for a series of prescribed ﬂow rates deliv-
ered by a syringe pump. The corresponding mass ﬂow
was quantiﬁed gravimetrically by means of a load cell.
Statistical analysis
The data presented throughout this work are expressed
as mean values standard error. All experiments were
repeated in triplicate, with a minimum of six samples
per material and/or treatment. Statistical signiﬁcance
was determined following student’s t-test or one-way
1030 Journal of Biomaterials Applications 29(7)
 at University of Strathclyde on January 14, 2015jba.sagepub.comDownloaded from 
analysis of variance (ANOVA) with post hoc testing
according to either Dunnett’s or Tukey’s procedure at
a 95% conﬁdence level (Minitab, software version 17).
The analysis was performed on the data acquired using
the plate reader (numbers of viable cells – as in Figure 4
and Table 2). Data were normalised in some cases with
respect to the untreated PDMS samples (Table 1) and
EPU catheter material after seeding (Figure 5).
Results
EPU characterisation
The morphology of the EPU catheter material was
determined by scanning electron microscopy; both
inner and outer surfaces are shown in Figure 2. The
plaques present on the inner surface of EPU are where
some of the polymer has ﬂowed onto the surface of the
mandrel during the electrospinning process, whereas
discrete ﬁbres are seen in the outer surface. The ﬁbre
diameter is in the range of 2–5 mm, and the pore size
9–15 mm. The thickness of the material was 150 mm.
Characterisation of cell growth under static
culture conditions
Fluorescence microscope images of astrocytes after
staining with Live/Dead Assay after 96 h in culture
on both treated and untreated samples are presented
in Figure 3. In all cases, according to the results of
Incubator at
37° C
EPU placed
inside the
T-25 flask
syringe pump
(0.07 ml/min)
Growth Medium
5% CO Cylinder2
Perfused
medium
Outflow of
growth
medium
through the
microporous
catheter
Luer connection
(blocks the outlet port)Obstructed EPU with cells
Inflow of
growth medium
from syringe
pump)
Figure 1. Schematic diagram of the shunt obstruction model. A syringe pump to delivered a constant flow of growth medium at a
rate of 0.07ml/min for 12 h through each EPU catheter, which was placed inside a T-25 flask. The T-25 flasks were placed inside an
incubator maintained at 37C and connected to a 5% CO2 cylinder. The growth medium was not recirculated but collected inside the
T-25 flask after passing through the walls of each catheter.
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the viability assay, more cells were present on the Fn-
BSA-treated samples in comparison to untreated sam-
ples, but the diﬀerence was signiﬁcant only for PDMS
(Table 1).
The numbers of NIH/3T3 cells cultured on untreated
PDMS, cast and electrospun forms of polyurethane,
and the SF were quantiﬁed according to the experimen-
tal protocol described in the Materials and methods
section (cell viability assessment), and the results com-
pared to those cells grown on plasma-treated tissue cul-
ture plastic (TCP) and silicone hydrogel controls
(Figure 4). The numbers of cells after 48 h and 96 h in
culture, expressed in terms of the percentage reduction
in AB dye, is presented in Figure 4. The silicone hydro-
gel (H) was used as a negative control on the basis that
this material would be less conducive to cell growth;
TCP, on the other hand, served as positive control,
this substrate having been plasma treated speciﬁcally
to promote cell attachment and proliferation. As
expected, the greatest reduction in AB was recorded
for the positive control, whereas the negative control
did not show an appreciable increase in cell numbers,
even after 96 h in culture. In contrast, all other sub-
strates show a marked diﬀerence in terms of the reduc-
tion in AB relative to the controls (p< 0.05) at both
time points.
PDMS, Z1A1 and Z3A1 were prepared in well plates
as before. The samples were then treated with proteins
(either BSA or ﬁbronectin adsorbed and blocked with
albumin (Fn-BSA)) and seeded with either NIH/3T3 or
astrocytes according to the above protocols. A com-
parison of cell viability for treated and untreated sam-
ples expressed relative to the untreated PDMS
substrate, for NIH/3T3 and astrocytes after 48 h and
96 h in culture, respectively, is presented in Table 1. It is
evident from the data presented in Table 1 that the
numbers of cells present on the treated and untreated
Z1A1 and Z3A1 are comparable to untreated PDMS
for both cell types and time points. NIH/3T3 cells on
BSA-treated PDMS at 48 h show signiﬁcantly lower
viability (p< 0.05) than other substrates, but at 96 h,
there is no diﬀerence (p¼ 0.163). Fn-BSA-treated
PDMS, on the other hand, supports signiﬁcantly
greater numbers of both cell types when compared to
untreated PDMS at both time points.
Quantification of hydraulic permeability and
shunt obstruction
Primary astrocytes and NIH/3T3 ﬁbroblasts were
seeded on the EPU catheters followed by perfusion in
the apparatus as illustrated in Figure 1 according to the
Table 1. The relative cell numbers on treated and untreated cast film polyurethane (PU) samples (Z1A1, Z3A1) in comparison to
untreated PDMS after 48 h and 96 h in static culture (NIH/3T3 cells and astrocytes).
48 h in culture 96 h in culture
Astrocytes NIII/3T3 cells Astrocytes NIII/3T3 cells
Untreated
BSA
Treated
Fn-BSA
Treated Untreated
BSA
Treated
Fn-BSA
Treated Untreated
BSA
Treated
Fn-BSA
Treated Untreated
BSA
Treated
Fn-BSA
Treated
PDMS O þ O  þ O þ O O þ
Z1A1 O O O O O O O O O O O O
Z3A1 O O O O O O O O O O O O
Note: PDMS: poly(dimethyl)siloxane; BSA: bovine serum albumin.
þDenotes significantly (p< 0.05) greater cell numbers, Denotes significantly fewer cells (p< 0.05) and o denotes no difference when compared to
untreated PDMS (determined by ANOVA with Dunnett’s post hoc test).
Table 2. Comparison of EPU catheter behaviour in the presence of NIH/3T3 fibroblasts and astrocytes.
Cell type
Cell viability (mean percentage reduction
of AB standard error)
Hydraulic permeability (mean standard
error; ml min1cm2mmHg1)
Post Seeding Post Perfusion No cells Post Perfusion
Astrocytes 11.11 0.71 16.56 1.26 0.062 0.003 0.040 0.003
NIH/3T3 11.49 0.97 19.01 1.28 0.071 0.002 0.029 0.005
Note: EPU: electrospun polyether urethane (Tecoflex).
Cell viability measured in terms of percentage of reduction for both post-seeding and post-perfusion samples (n¼ 3).
Hydraulic permeability was determined both in the presence and absence of cells.
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methods described in the Materials and methods sec-
tion. Catheter samples were incubated with AB-supple-
mented medium 6h after seeding and again 12 h of
perfusion. Cell viability was determined post seeding
(after 6 h) and post perfusion (after 12-h perfusion
and 6 h exposure to AB). The results are presented in
Table 2. The numbers of cells present on the catheter
material were no diﬀerent for either cell type, either
before or after perfusion (p value¼ 0.09). In all cases,
the hydraulic permeability of each catheter at the end of
the perfusion experiment revealed a signiﬁcant decrease
(p< 0.05) irrespective of the cell type (Table 2).
In a further series of experiments, the EPU catheters
were ﬁrst treated with ﬁbronectin and blocked with
albumin and then seeded with NIH/3T3 cells as
described above. As a control group, a number of
EPU catheters (n¼ 3) were seeded with cells and main-
tained under static conditions. The results of cell via-
bility after seeding and at the end of perfusion/static
EPU catheters are summarised in Figure 5. The
numbers of cells on the Fn-BSA treated and untreated
samples increased signiﬁcantly (p< 0.05) for both static
and post-perfusion samples compared to the numbers
immediately after seeding. Untreated and Fn-BSA-
treated samples fail to show any signiﬁcant change in
cell numbers either during perfusion or after static
culture.
At the conclusion of each test, the hydraulic perme-
ability of all EPU catheters was quantiﬁed and com-
pared with the values obtained for each sample
beforehand. The results of this comparison are pre-
sented in Figure 6 in terms of hydraulic permeability
before seeding (no cells present) and at the conclusion
of each experiment. Despite a signiﬁcant reduction
(p< 0.05) in hydraulic permeability owing to cell
obstruction under perfusion or static conditions, we
calculate that an obstructed EPU catheter having
dimensions equivalent to those of an actual ventricular
catheter would still be capable of clearing CSF at a rate
of 0.35ml/min.
Figure 2. SEM micrographs illustrating the range of morphologies of the EPU catheters used in this study. Representative images of
the inner (a–c) and outer (d–f) surfaces of the material are shown (scale bar 100 mm). Higher magnification images (g–i) show the outer
surface with a scale bar of 30mm.
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Discussion
CSF shunt technology, and the proximal catheter, in
particular, has not beneﬁtted from any major advance-
ment in terms of materials and surface modiﬁcation
seen in other applications, for example, the cardiovas-
cular system. Conventional proximal catheters are
made of PDMS, and are perforated with up to 40 dis-
crete holes, each 0.5–1mm in diameter. To our know-
ledge, there is no record that any other materials or
forms have been considered for this application. In an
eﬀort to maintain a more uniform distribution of ﬂow,
however, other researchers have examined the eﬀect of
increasing the size and location of the perforations.
PDMS
Z1A1
Z3A1
SF
Fn-BSA Treated Non-Treated
Figure 3. Fluorescence images of astrocytes taken after 96 h in culture on Fn-BSA-treated and untreated samples. Live cells are
stained green (Calcein AM) and dead cells are stained red (ethidium homodimer – 1). Scale bars are 20mm.
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Lin et al.,11 for example, suggested that by increasing
the size of holes located closer to the tip of the catheter,
the ﬂow entering the catheter is distributed more uni-
formly along its length. Similarly, Thomale et al.6
demonstrated that the clinical performance of a cath-
eter is improved if it has fewer, larger holes. Harris and
McAllister12 postulated that such a conﬁguration gives
rise to a better ﬂow distribution. The results from the
latter study show that larger holes generated less resist-
ance and the lowest shear stress. In both studies,6,12 the
uniformity of ﬂow was found to increase with increas-
ing size of the perforations, while the overall area avail-
able to ﬂow was maintained the same.
Materials consideration
The ﬁndings of this investigation support the hypoth-
esis that polyurethane is a viable alternative to PDMS
under static culture conditions (Table 1). The results
also shed some light on how the cells behave on each
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Figure 5. Relative cell viability after 12-h perfusion and static culture on untreated and Fn-BSA-treated EPU catheters. Data are
expressed as a percentage relative to values obtained for control samples immediately after seeding (mean standard error; n¼ 8). (*)
Denotes a significant difference (p< 0.05) as determined by ANOVA and Tukey’s post hoc analysis.
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substrate. While there was no signiﬁcant diﬀerence
between the cast ﬁlm polyurethanes for both the time
points, there was a signiﬁcant diﬀerence on protein-
treated PDMS after 48 h but not after 96 h in culture.
These results suggest that, initially, the polyurethanes
do not encourage cell proliferation to the same degree
as PDMS, however cells do appear to adapt to grow on
these surfaces after a longer period in culture; with
more time, it is likely that cells grown on impermeable
forms of PDMS and polyurethane will eventually
populate the entire surface of the substrate. It follows
that substituting polyurethane for PDMS may not oﬀer
any advantage or overcome the drawbacks of conven-
tional catheters made of this material. The same could
be said of the macroporous sponge forms, which do not
show a signiﬁcant diﬀerence to cast ﬁlm PDMS at both
time points (Figure 4).
The topography, roughness and charge of the mater-
ial surfaces each play an important part in cell attach-
ment.13Reports in the literature suggest that the greater
porosity and interconnectivity of microporous mater-
ials oﬀer better nutrient and waste transport, and
mimic more eﬀectively the extra cellular matrix by pro-
viding structural and functional cues found in
nature.17,18 At higher cell densities, however, cells are
likely to become contact inhibited (on reaching conﬂu-
ence). The increased surface area of EPU in this context
may impair such interactions, at least at the seeding
densities and time points used in this study, which
showed that cells on the porous forms of each material
fared no better or worse than on the cast ﬁlms. One
explanation for this observation might be the use of the
unmodiﬁed EPU as a substrate. It is known that mod-
ifying the ﬁbres with poly-D-lysine or similar com-
pounds initiates better adhesion and cell survival;18
equally, the choice of polymer, which does not readily
promote cell attachment without modiﬁcation with
extracellular matrix components.19
Cell growth on the surfaces examined as part of this
study is a function of many factors, including cell type
and seeding density, and the presence or absence of
soluble factors in the medium such a growth factors
and proteins. The interaction of the latter with the sur-
face depends on adsorption kinetics and surface prop-
erties, including surface chemistry, charge, wettability,
hydrogen bonding, ionic interaction, calcium bridges
between carboxyl groups and time of exposure.20 Is it
surprising, therefore, that cell growth was the same for
all substrates and forms, regardless of surface treat-
ment, with the exception of Fn-BSA-treated PDMS at
48 h and 96 h, which supported greater numbers of cells
than untreated PDMS or PU (Table 1; see also
Figure 3). This result may be due to the relatively low
protein concentrations used in this study, however.
The use of silicone hydrogel as a negative control
surface in the present study points to the use of such
materials as a way of minimising protein adsorption,
through the use of superhydrophilic materials or coat-
ings, for example, or by means of surface modiﬁcation
strategies like those proposed by Harris and cowor-
kers,13,14 who plasma-treated PDMS catheter materials
in order to render their surfaces more hydrophilic.
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Figure 6. Hydraulic permeability compared with no cells present (before seeding) and 12 h after perfusion/static culture conditions
for untreated and Fn-BSA-treated EPU catheters. Data points represent mean standard error mean and n¼ 8. (*) Denotes a
significant difference (p< 0.05) in permeability after perfusion/static culture relative to the control (before seeding) as determined by
ANOVA with Tukey’s post hoc analysis.
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Hydraulic performance
The hydraulic performance of an EPU catheter mater-
ial was evaluated in the presence of cells and proteins
present in CSF. Here, the adhesion of immortalised 3T3
cells and astrocytes were compared under perfusion
conditions for a set of untreated EPU catheters: there
was no signiﬁcant diﬀerence in terms of cell number
(Table 2). In all subsequent experiments, therefore,
the NIH/3T3 cell line was used instead of primary
astrocytes. Treating the surface of each sample before-
hand with ﬁbronectin and albumin did not enhance cell
adhesion or growth either (Figure 5). Likewise perfu-
sion, which for NIH/3T3 cells at least, does not inﬂu-
ence cell growth (p> 0.05), although it would be
premature to infer from these ﬁndings that the ﬂow
of medium through the pores of the material does not
have a bearing on cell proliferation. It may be that
some cells proliferate more in some areas, while
others are inhibited or removed under perfusion; this
is unlikely, however, as there was no evidence of viable
cells present either in the medium or on the surface of
the T25 ﬂask at the conclusion of the perfusion
experiments.
Even though the initial seeding density was higher, it
remains a distinct possibility that a higher seeding dens-
ity and perfusion over an extended period could give
rise to quantiﬁable diﬀerences between static and per-
fusion cultures. The only conclusion that we can draw
at this stage is that the measure of hydraulic permeabil-
ity reveals the contribution made by cells on the per-
meability of EPU catheters. Clearly, the physical
presence of cells on the surfaces of the EPU material
gives rise to a signiﬁcant decrease in permeability,
which would result in a reduction in CSF ﬂow that
had the measurement been made under pressure
control.
An understanding of the behaviour of cells in the
presence of ﬂow is critical in this context. Cell behav-
iour is mediated by many factors, both chemical and
physical. The need to study obstruction of catheter
materials under realistic ﬂow conditions was clearly
outlined by Harris et al.21 Hence, cell adhesion and
growth under physiological ﬂow conditions in vitro
takes us one step closer to understanding how these
materials might perform within the ventricular
microenvironment.
The number of viable cells on each sample of cath-
eter material was the same overall regardless of the
treatments or culture conditions, or hydraulic perme-
ability. This result is surprising insofar as other studies
have reported that porosity and size of pores have a
bearing on the ability of ability ﬁbroblasts and astro-
cytes to bridge the pores.22 When cell inﬁltration is
limited by very small pore sizes, cell adhesion is
unaﬀected. On the other hand, large pores may not
retain cells to the same extent. Indeed it has been
shown that cells become quiescent if the pore diameter
is more than 20 mm in electrospun polymers.23
The model of shunt catheter obstruction showed a
signiﬁcant decrease in hydraulic permeability for all
samples. The obvious inference is that the cells and
cell debris have blocked the pores resulting in a reduc-
tion in ﬂow though the catheter when subjected to a
ﬁxed pressure gradient. Remarkably, there was no dif-
ference noted in the blockage between perfusion or
static, and Fn-BSA-treated and untreated samples.
Although ﬂow through the obstructed EPU was
reduced almost threefold for all the samples, the cath-
eter material remains permeable to ﬂow. As the pres-
sure gradient across the walls of the catheter rises,
however, there would likely be a corresponding increase
in ﬂow entering the catheter. The extent to which cell
obstruction aﬀects the catheter permeability and CSF
ﬂow over longer periods remains to be shown, but any
reduction in ﬂow could be overcome in terms of cath-
eter design, through an increase in available surface
area, or the introduction of fenestration, for example.
The cell culture techniques employed in this study
are a poor representation of the microenvironment pre-
sent within the ventricular system of the brain. The
choice of materials, cell types, seeding densities, time
points and duration of study cannot be expected to
replicate the complex interactions between an
implanted device and host in a manner that can predict
long-term performance or replicate failure modes. The
present study made use of two cell types, primary astro-
cytes and an immortalised cell line, but explant studies
conﬁrm that other cell types are involved, for example,
macrophages.6 The NIH/3T3 cell line was chosen for
practical and cost considerations. Nevertheless, having
established that the behaviour of the latter cells on the
substrates used in this study was similar to astrocytes,
these cells were considered a suitable model for shunt
obstruction. In further studies, however, it is recom-
mended that such experiments are conducted using
cocultures of macrophages and astrocytes to replicate
better the conditions present in vivo, and to elucidate
the role of inﬂammatory cells and signalling involved in
mediating the host response to the implanted materials.
For longer term studies, consideration should be given
to the use of animal models, where local and systemic
responses and device performance can be studied along
with adverse events.
Conclusions
An evaluation of alternative materials has been con-
ducted under static and dynamic conditions represen-
tative of CSF shunt transport in vivo. The results show
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that cell growth and viability are largely dependent on
the material and form of the substrate, and to a lesser
extent the culture conditions. This is the ﬁrst study, to
our knowledge, to consider electrospun materials as a
ventricular catheter material. These preliminary results
warrant further investigation since a relatively modest
reduction in terms of the impact of cell overgrowth on
catheter permeability may translate to a reduction in
the complications associated with shunt catheter
obstruction.
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